New scan could replace biopsies for breast cancer patients
NCT ID NCT07294430
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tests a new imaging method (antibody-based PET scan) to see if it can predict how well a targeted cancer drug (T-DXd) works in people with advanced breast cancer. The goal is to potentially replace tumor biopsies with a less invasive scan. About 30 participants already in another study (OASIS) will receive the scan before and during treatment to check for early signs of response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.